Drug Master Files for: AMPICILLIN SODIUM
✉ Email this page to a colleague
AMPICILLIN SODIUM Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 11450 | I | II | 4/14/1995 | CONSOLIDATED PHARMACEUTICAL GROUP INC | AMPICILLIN TRIHYDRATE BPC |
| 11482 | I | II | 4/28/1995 | CONSOLIDATED PHARMACEUTICAL GROUP INC | AMPICILLIN TRIHYDRATE FOR ORAL SUSPENSION |
| 11484 | I | II | 4/28/1995 | CONSOLIDATED PHARMACEUTICAL GROUP INC | AMPICILLIN TRIHYDRATE CAPSULES |
| 13212 | A | II | 4/30/1998 | SANDOZ INDUSTRIAL PRODUCTS SA | AMPICILLIN ANHYDROUS |
| 13296 | I | II | 9/1/1998 | SMITHKLINE BEECHAM PHARMACEUTICALS | AMPICILLIN TRIHYDRATE |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
